See All Slides - tctmd.com

Slides

Presentation TCT 2015

Malaysia Presents: Tangled Web MitraClip Case

Presenter: Mohammad Al-Mutairi, Amal Kumar Banerjee, Ahmed Magdy, Robaayah Zambahari, M Nasir Muda

October 12, 2015

Presentation TCT 2015

Is Hemodynamic Collapse Due to Increased Afterload After MV Replacement in Severe MR With Reduced LVEF a Real Phenomenon?

Presenter: Michael J. Mack, Francesco Maisano, Patrick M. McCarthy

October 12, 2015

Presentation TCT 2015

Problem (and Solution) 1: The Ambiguous or Impenetrable Proximal Cap

Presenter: Javier Escaned, William L. Lombardi, Ashish Pershad

October 12, 2015

Presentation TCT 2015

Debate: Can Todays Metallic Stent Platforms, Delivery Systems, and Durable Polymers Be Meaningfully Improved? Yes, Made Thinner and More Flexible, With Optimally Designed Platforms and Enhanced Polymers There Is Still Room for Improvement!

Presenter: Fernando Alfonso, Juan F. Granada, Elazer R. Edelman

October 12, 2015

Presentation TCT 2015

For Years Weve Been Hearing Surgical MV Repair Is Always Preferable to Replacement So, Why Transcatheter MV Replacement?!

Presenter: Michael J. Mack, Francesco Maisano, John G. Webb

October 12, 2015

Presentation TCT 2015

Technical Overview of FDA-Approved and CE-Marked DCB Technologies for PVD Intervention

Presenter: Greg L. Kaluza, Thomas Zeller

October 12, 2015

Presentation TCT 2015

ABSORB III: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold Vs. an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Presenter: Ioanna Kosmidou, Dean J. Kereiakes

October 12, 2015

Presentation TCT 2015

Latest Advances in Medical and Device-Based Therapies for Heart Failure

Presenter: Daniel Burkhoff, Ileana L. Pina, JoAnn Lindenfeld

October 12, 2015

Presentation TCT 2015

Bivalirudin vs Heparin in ACS: The New Data MATRIX Antithrombin Results

Presenter: John A. Bittl, Robert A. Harrington, Marco Valgimigli

October 12, 2015

Presentation TCT 2015

Structural Intervention: LAA Closure, HOCM, and Paravalvular Leak

Presenter: Srihari S. Naidu, Adnan K. Chhatriwalla

October 12, 2015

Advertisement

Slides

Malaysia Presents: Tangled Web MitraClip Case

Is Hemodynamic Collapse Due to Increased Afterload After MV Replacement in Severe MR With Reduced LVEF a Real Phenomenon?

Problem (and Solution) 1: The Ambiguous or Impenetrable Proximal Cap

Debate: Can Todays Metallic Stent Platforms, Delivery Systems, and Durable Polymers Be Meaningfully Improved? Yes, Made Thinner and More Flexible, With Optimally Designed Platforms and Enhanced Polymers There Is Still Room for Improvement!

For Years Weve Been Hearing Surgical MV Repair Is Always Preferable to Replacement So, Why Transcatheter MV Replacement?!

Technical Overview of FDA-Approved and CE-Marked DCB Technologies for PVD Intervention

ABSORB III: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold Vs. an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Latest Advances in Medical and Device-Based Therapies for Heart Failure

Bivalirudin vs Heparin in ACS: The New Data MATRIX Antithrombin Results

Structural Intervention: LAA Closure, HOCM, and Paravalvular Leak

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content